EC Number | Application | Comment | Organism |
---|---|---|---|
2.4.1.310 | synthesis | in vitro sequential glycosylations of the vancomycin aglycon catalyzed by the glycosyltransferases GtfE and GtfD and total synthesis of vancomycin and derivatives. For GtfE, presence of reductant tris(2-carboxyethyl)phosphine (TCEP, 2 mM) is crucial | Amycolatopsis orientalis |
2.4.1.322 | synthesis | in vitro sequential glycosylations of the vancomycin aglycon catalyzed by the glycosyltransferases GtfE and GtfD and total synthesis of vancomycin and derivatives | Amycolatopsis orientalis |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.4.1.310 | expression in Escherichia coli | Amycolatopsis orientalis |
2.4.1.322 | expression in Escherichia coli | Amycolatopsis orientalis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.310 | CHAPS | - |
Amycolatopsis orientalis | |
2.4.1.310 | Triton X-100 | - |
Amycolatopsis orientalis | |
2.4.1.310 | Tween 20 | - |
Amycolatopsis orientalis |
EC Number | Organic Solvent | Comment | Organism |
---|---|---|---|
2.4.1.310 | DMSO | up to 10% v/v, tolerated | Amycolatopsis orientalis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.310 | Amycolatopsis orientalis | - |
- |
- |
2.4.1.310 | Amycolatopsis orientalis ATCC 19795 | - |
- |
- |
2.4.1.322 | Amycolatopsis orientalis | Q9AFC7 | - |
- |
2.4.1.322 | Amycolatopsis orientalis ATCC 19795 | Q9AFC7 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.310 | additional information | study on reaction after modification of the vancomycin aglycon. Modification at the N-terminus amine of vancomycin aglycon is well tolerated, whereas C-terminus modification with removal of the acidic carboxylic acid results in a slower, less effective initial glycosylation | Amycolatopsis orientalis | ? | - |
? | |
2.4.1.310 | additional information | study on reaction after modification of the vancomycin aglycon. Modification at the N-terminus amine of vancomycin aglycon is well tolerated, whereas C-terminus modification with removal of the acidic carboxylic acid results in a slower, less effective initial glycosylation | Amycolatopsis orientalis ATCC 19795 | ? | - |
? | |
2.4.1.310 | UDP-alpha-D-glucose + vancomycin aglycone | - |
Amycolatopsis orientalis | UDP + devancoaminyl vancomycin | - |
? | |
2.4.1.310 | UDP-alpha-D-glucose + vancomycin aglycone | - |
Amycolatopsis orientalis ATCC 19795 | UDP + devancoaminyl vancomycin | - |
? | |
2.4.1.322 | dTDP-beta-L-vancosamine + desvancosaminyl-vancomycin | - |
Amycolatopsis orientalis | dTDP + vancomycin | - |
? | |
2.4.1.322 | dTDP-beta-L-vancosamine + desvancosaminyl-vancomycin | - |
Amycolatopsis orientalis ATCC 19795 | dTDP + vancomycin | - |
? | |
2.4.1.322 | additional information | modification of the C- or N-terminus of the vancomycin aglycon does not inhibit completion of the transfer reaction | Amycolatopsis orientalis | ? | - |
? | |
2.4.1.322 | additional information | modification of the C- or N-terminus of the vancomycin aglycon does not inhibit completion of the transfer reaction | Amycolatopsis orientalis ATCC 19795 | ? | - |
? | |
2.4.1.322 | UDP-beta-L-vancosamine + desvancosaminyl-vancomycin | - |
Amycolatopsis orientalis | dUDP + vancomycin | - |
? | |
2.4.1.322 | UDP-beta-L-vancosamine + desvancosaminyl-vancomycin | - |
Amycolatopsis orientalis ATCC 19795 | dUDP + vancomycin | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.1.310 | GtfE | - |
Amycolatopsis orientalis |